Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crispr Therapeutics AG (CRSP) vs Iron Mountain Inc (IRM) Price & Performance

Crispr Therapeutics AGTrade
Iron Mountain IncTrade

Price performance (Past 24H)

Key statistics

Crispr Therapeutics AG vs Iron Mountain Inc — how do they compare? Crispr Therapeutics AG trades at $54.07 (market cap $5.23B), while Iron Mountain Inc trades at $122.41 (market cap $36.44B). The key difference: Iron Mountain Inc is far larger — about 7× Crispr Therapeutics AG's market cap, and Iron Mountain Inc pays a 2.82% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

CRSPIRM
Market Cap
$5.23B$36.44B
Sector
HealthReal Estate
52-Week High
$76.78$133.06
52-Week Low
$44.34$78.86
Enterprise Value
$3.65B$55.85B
Dividend Yield
2.82%

Returns comparison

Trailing returns across standard periods

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP

About Iron Mountain Inc

Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business

Read more on IRM